(Q34416193)

2 August 2017

title

Recent progress in the understanding and treatment of transthyretin amyloidosis (English)

1 reference

2 August 2017

1 reference

ChEBI release 2020-05-28

Y Sekijima

1

1 reference

2 August 2017

language of work or name

1 reference

1 June 2014

1 reference

Journal of Clinical Pharmacy and Therapeutics

2 August 2017

published in

1 reference

2 August 2017

volume

39

1 reference

2 August 2017

issue

3

1 reference

2 August 2017

page(s)

225-233

1 reference

Amyloid fibril protein nomenclature: 2012 recommendations from the Nomenclature Committee of the International Society of Amyloidosis

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Amyloid deposits and amyloidosis: the beta-fibrilloses (second of two parts).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Pathogenesis of and therapeutic strategies to ameliorate the transthyretin amyloidoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Fibril in senile systemic amyloidosis is derived from normal transthyretin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Geographical distribution of TTR met30 carriers in northern Sweden: discrepancy between carrier frequency and prevalence rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Heterogeneity of penetrance in familial amyloid polyneuropathy, ATTR Val30Met, in the Swedish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

A prospective evaluation of the transthyretin Ile122 allele frequency in an African-American population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Clinicopathological features of senile systemic amyloidosis: an ante- and post-mortem study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

High prevalence of ATTR amyloidosis in endomyocardial biopsy-proven cardiac amyloidosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

The premortem recognition of systemic senile amyloidosis with cardiac involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

High prevalence of wild-type transthyretin deposition in patients with idiopathic carpal tunnel syndrome: a common cause of carpal tunnel syndrome in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Wild-type transthyretin-derived amyloidosis in various ligaments and tendons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Synovial deposition of wild-type transthyretin-derived amyloid in knee joint osteoarthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Non-senile wild-type transthyretin systemic amyloidosis presenting as bilateral carpal tunnel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Localization of the human prealbumin gene to chromosome 18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Structure of the chromosomal gene for human serum prealbumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

High prealbumin and transferrin mRNA levels in the choroid plexus of rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Disruption of the transthyretin gene results in mice with depressed levels of plasma retinol and thyroid hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Thyroxine-induced conformational changes in prealbumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Transport of thyroid hormones in serum and cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Structure of a complex of two plasma proteins: transthyretin and retinol-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Transthyretin mutation Leu-55-Pro significantly alters tetramer stability and increases amyloidogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Comparison of Lethal and Nonlethal Transthyretin Variants and Their Relationship to Amyloid Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

The pathway by which the tetrameric protein transthyretin dissociates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Kinetic stabilization of the native state by protein engineering: implications for inhibition of transthyretin amyloidogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Serum transthyretin monomer in patients with familial amyloid polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Transthyretin slowly exchanges subunits under physiological conditions: A convenient chromatographic method to study subunit exchange in oligomeric proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Transthyretin aggregation under partially denaturing conditions is a downhill polymerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Sequence-dependent denaturation energetics: A major determinant in amyloid disease diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

D18G transthyretin is monomeric, aggregation prone, and not detectable in plasma and cerebrospinal fluid: a prescription for central nervous system amyloidosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

The biological and chemical basis for tissue-selective amyloid disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Hydration and packing are crucial to amyloidogenesis as revealed by pressure studies on transthyretin variants that either protect or worsen amyloid disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Quantification of the thermodynamically linked quaternary and tertiary structural stabilities of transthyretin and its disease-associated variants: the relationship between stability and amyloidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Trans-suppression of misfolding in an amyloid disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Support for the multigenic hypothesis of amyloidosis: the binding stoichiometry of retinol-binding protein, vitamin A, and thyroid hormone influences transthyretin amyloidogenicity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Endoplasmic reticulum quality control regulates the fate of transthyretin variants in the cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Marked regression of abdominal fat amyloid in patients with familial amyloid polyneuropathy during long-term follow-up after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Long-term data from the Familial Amyloidotic Polyneuropathy World Transplant Registry (FAPWTR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Long-term survival after liver transplantation in patients with familial amyloid polyneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Deposition and passage of transthyretin through the blood-nerve barrier in recipients of familial amyloid polyneuropathy livers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Inhibiting transthyretin amyloid fibril formation via protein stabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Prevention of transthyretin amyloid disease by changing protein misfolding energetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Native state stabilization by NSAIDs inhibits transthyretin amyloidogenesis from the most common familial disease variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Native state kinetic stabilization as a strategy to ameliorate protein misfolding diseases: a focus on the transthyretin amyloidoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Kinetic stabilization of an oligomeric protein under physiological conditions demonstrated by a lack of subunit exchange: implications for transthyretin amyloidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Kinetic stabilization of an oligomeric protein by a single ligand binding event

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Orally administered diflunisal stabilizes transthyretin against dissociation required for amyloidogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Tafamidis for transthyretin amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Inosine(15.1) hammerhead ribozymes for targeting the transthyretin-30 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Selective silencing of a mutant transthyretin allele by small interfering RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Safety and efficacy of RNAi therapy for transthyretin amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Targeted suppression of an amyloidogenic transthyretin with antisense oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Suppression of choroid plexus transthyretin levels by antisense oligonucleotide treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Targeted conversion of the transthyretin gene in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

R104H may suppress transthyretin amyloidogenesis by thermodynamic stabilization, but not by the kinetic mechanism characterizing T119 interallelic trans-suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Diflunisal stabilizes familial amyloid polyneuropathy-associated transthyretin variant tetramers in serum against dissociation required for amyloidogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Liver Transplantation for Familial Amyloidotic Polyneuropathy (FAP): A Single-Center Experience Over 16 Years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

The amyloidogenic potential of transthyretin variants correlates with their tendency to aggregate in solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

The Tetrameric Protein Transthyretin Dissociates to a Non-native Monomer in Solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Tabulation of human transthyretin (TTR) variants, 2003

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Senile systemic amyloidosis, cerebral amyloid angiopathy, and dementia in a very old Finnish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Senile systemic amyloidosis presenting as bilateral carpal tunnel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Clinical development of an antisense therapy for the treatment of transthyretin-associated polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

Electron Microscopic Observations on a Fibrous Component in Amyloid of Diverse Origins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12145

21 January 2018

Identifiers

DOI

10.1111/JCPT.12145

1 reference

2 August 2017

1 reference